AIM IMMUNOTECH INC. Finite-Lived Intangible Asset, Expected Amortization, Year One
AIM IMMUNOTECH INC. (AIM) had Finite-Lived Intangible Asset, Expected Amortization, Year One of $156.00 thousand as of 2026-06-30, per its 10-Q filed 2026-08-07.
Financial Statements › Notes › Goodwill and Other › Intangible Asset, Finite-Lived, and Capitalized Cost, Software to be Sold, Leased, or Marketed, Estimated Amortization Expense › Intangible Asset, Finite-Lived, after Accumulated Amortization, Estimated Amortization Expense, Fiscal Year Maturity
us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths · last filed 2026-08-07
- 2026-06-30: Finite-Lived Intangible Asset, Expected Amortization, Year One $156.00K.
- 2026-03-31: Finite-Lived Intangible Asset, Expected Amortization, Year One $115.00K.
- 2025-12-31: Finite-Lived Intangible Asset, Expected Amortization, Year One $164.00K.
- 2025-09-30: Finite-Lived Intangible Asset, Expected Amortization, Year One $229.00K.
| Period end | Finite-Lived Intangible Asset, Expected Amortization, Year One |
|---|---|
| 2026-06-30 | $156.00K 10-Q · filed 2026-08-07 |
| 2026-03-31 | $115.00K 10-Q · filed 2026-05-15 |
| 2025-12-31 | $164.00K 10-K · filed 2026-03-27 |
| 2025-09-30 | $229.00K 10-Q · filed 2025-11-17 |
| 2025-06-30 | $297.00K 10-Q · filed 2025-08-14 |
| 2025-03-31 | $233.00K 10-Q · filed 2025-05-15 |
| 2024-12-31 | $283.00K 10-K · filed 2025-03-27 |
| 2024-09-30 | $268.00K 10-Q · filed 2024-11-14 |
| 2024-06-30 | $258.00K 10-Q · filed 2024-08-14 |
| 2024-03-31 | $237.00K 10-Q · filed 2024-05-15 |
| 2023-12-31 | $241.00K 10-K · filed 2024-04-01 |
| 2023-09-30 | $225.00K 10-Q · filed 2023-11-14 |
| 2023-06-30 | $212.00K 10-Q · filed 2023-08-14 |
| 2023-03-31 | $167.00K 10-Q · filed 2023-05-15 |
| 2022-12-31 | $177.00K 10-K · filed 2023-03-31 |
| 2022-09-30 | $154.00K 10-Q · filed 2022-11-14 |
| 2022-06-30 | $156.00K 10-Q · filed 2022-08-15 |
| 2022-03-31 | $153.00K 10-Q · filed 2022-05-13 |
| 2021-12-31 | $75.00K 10-K · filed 2022-03-31 |
| 2021-09-30 | $140.00K 10-Q · filed 2021-11-15 |
| 2021-06-30 | $137.00K 10-Q · filed 2021-08-16 |
| 2021-03-31 | $132.00K 10-Q · filed 2021-05-17 |
| 2020-12-31 | $75.00K 10-K · filed 2021-03-31 |
| 2014-12-31 | $31.00K 10-K · filed 2015-03-19 |
| 2013-12-31 | $20.00K 10-K · filed 2014-03-14 |
| 2012-12-31 | $15.00K 10-K · filed 2013-03-18 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| CREATIVE MEDICAL TECHNOLOGY HOLDINGS, INC. (CELZ) | United States | $0.006B | |
| CERO THERAPEUTICS HOLDINGS, INC. (CERO) | United States | $0.007B | |
| PharmaCyte Biotech, Inc. (PMCB) | United States | $0.005B | |
| TScan Therapeutics, Inc. (TCRX) | United States | $0.008B | -1.23 |
| WINDTREE THERAPEUTICS INC /DE/ (WINT) | United States | $0.003B | -0.32 |
| VivoSim Labs, INC. (VIVS) | United States | $0.003B | |
| Calidi Biotherapeutics, Inc. (CLDI) | United States | $0.003B | |
| CURIS INC (CRIS) | United States | $0.002B | -0.05 |
| Senti Biosciences Holdings, Inc. (SNTI) | United States | $0.011B | -0.70 |
| Silexion Therapeutics Corp (SLXN) | $0.001B |